List of Novartis's Acquisitions
Here's the year on year acquisition history of Novartis:
Year | # Acquisitions |
|---|---|
2026 | 2 |
2025 | 4 |
2024 | 5 |
2023 | 2 |
2022 | 1 |
2021 | 2 |
2020 | 3 |
2019 | 1 |
2018 | 2 |
2017 | 1 |
2016 | 5 |
2015 | 2 |
2014 | 1 |
2012 | 1 |
2011 | 1 |
2010 | 1 |
2009 | 2 |
2008 | 2 |
2006 | 2 |
2005 | 2 |
2002 | 1 |
1997 | 1 |
Recent acquisitions by Novartis
Novartis's most recent acquisition - Myricx Bio is a Developer of antibody drug conjugates for the treatment of cancer, founded in 2019 and located in London. Novartis acquired it in July 2026 for a price of $*****.
Here is the list of all acquisitions by Novartis sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Jul 06, 2026 | exmj | meig | 17 | 103 | |
Mar 27, 2026 | jexd | icdh | 67 | 501 | |
Oct 27, 2025 | zwwc | bbtw | 58 | 639 | |
Sep 09, 2025 | {ksh | zigc | 18 | 691 | |
Apr 30, 2025 | vxps | soni | 12 | 609 |
View the full list of acquisitions
Sign Up for FreeNews related to Novartis's acquisitions
Media has covered Novartis for a total of 171 events in the last 1 year, 37 of them have been about acquisition activity.
•
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis ProductMedCity News•Jul 30, 2026•Novartis
•
•
Cognizant Expands Long-Standing Partnership with Novartis for AI-Enabled IT OperationsEuropean Pharmaceutical Manufacturer•Jul 28, 2026•Cognizant, Novartis
•
Chai Discovery Raises $400M Series C, Valued at $3.8B, for AI-Designed AntibodiesSiliconAngle•Jul 14, 2026•Pfizer, Novartis, Chai Discovery, Lilly
•
ChrysCapital's Open Offer for Novartis India Fails Amidst Share SurgeVCCircle•Jul 10, 2026•ChrysCapital, Novartis
•
Novartis strikes $1.5B deal for UK biotech Myricx BioSeeking Alpha•Jul 06, 2026•Novartis, Myricx Bio, Sofinnova Partners, Brandon Capital and 2 others
•
Novartis and Antares Therapeutics Announce Strategic Oncology CollaborationBioSpace•Jun 24, 2026•Novartis, Antares Pharma, Antares
•
•
•
Orionis Biosciences and Novartis Partner to Advance Molecular Glue DrugsContract Pharma•Jun 10, 2026•Orionis Biosciences, Novartis